Skip to main content
padlock icon - secure page this page is secure
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 17, Number 3, 2016

Articles

Free Content Graphical Abstracts:
pp. i-iv(4)

Favourites:
ADD

Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer
pp. 1-13(13)
Authors: Msaouel, Pavlos; Galeas, Jose N.; Boiles, Alejandro Recio; Ruiz, Ramiro Rancier; Koutsilieris, Michael

Favourites:
ADD

Free Content Meet Our Editorial Board Member
pp. 253-253(1)
Author: L. Sheets, Patrick

Favourites:
ADD

Free Content Editorial (Thematic Issue: New Drug Targets for Treatment of Recurrent/Metastatic Prostate Cancer)
pp. 254-256(3)
Authors: Festuccia, Claudio; Negri-Cesi, Paola; Gravina, Giovanni L.

Favourites:
ADD

MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs
pp. 257-265(9)
Authors: Pennati, Marzia; Folini, Marco; Gandellini, Paolo; Zaffaroni, Nadia

Favourites:
ADD

Emerging Targets For Prostate Adenocarcinoma Therapy: How Molecular Biology May Drive Towards a More Tailored Approach
pp. 266-275(10)
Authors: Ambrosio, Maria R.; Pirtoli, Luigi; del Vecchio, Maria Teresa

Favourites:
ADD

New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer
pp. 290-302(13)
Authors: Assi, Rita; Temraz, Sally; Shamseddine, Ali; Mukherji, Deborah

Favourites:
ADD

Nanoparticles-Based Treatment for Bone Metastasis
pp. 303-310(8)
Authors: Saracino, Rossana; Luciano, Rosa; Battafarano, Giulia; Perrotta, Antonio; Muraca, Maurizio; Fattore, Andrea D.

Favourites:
ADD

Targeting the NF-ΚB pathway in prostate cancer: a promising therapeutic approach?
pp. 311-320(10)
Authors: Verzella, Daniela; Fischietti, Mariafausta; Capece, Daria; Vecchiotti, Davide; Del Vecchio, Filippo; Cicciarelli, Germana; Mastroiaco, Valentina; Tessitore, Alessandra; Alesse, Edoardo; Zazzeroni, Francesca

Favourites:
ADD

Therapeutic Value of an Integrin Antagonist in Prostate Cancer
pp. 321-327(7)
Author: Philippe, Clément-Lacroix

Favourites:
ADD

Anti-VEGF Therapy for Retinal Vein Occlusions
pp. 328-336(9)
Authors: Campa, Claudio; Alivernini, Giuseppe; Bolletta, Elena; Parodi, Maurizio B.; Perri, Paolo

Favourites:
ADD

Current Perspectives on Novel Drug Delivery Systems and Approaches for Management of Cervical Cancer: A Comprehensive Review
pp. 337-352(16)
Authors: Hani, Umme; Osmani, Riyaz Ali M.; Bhosale, Rohit R.; Shivakumar, Hosakote G.; Kulkarni, Parthasarathi K.

Favourites:
ADD

New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer
pp. 353-374(22)
Authors: Savoia, Paola; Cremona, Ottavio; Fava, Paolo

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more